TRENDING :  Market Movers  |  Top 50   SPY (-0.31%)    TSLA (-6.03%)    BYND (0.17%)    BTCUSD (%)    FTNT (-0.73%)    ELTK (-3.03%)    CANF (-7.48%)    ARQL (0.56%)    MCHP (-0.15%)    ONCS (-32.5%)    VXX (-0.95%)    IP (-1.4%)    INTC (-1.04%)    GTN (-1.44%)    GLW (0.1%)    ANY (-1.05%)    AMZN (0.12%)    AMPH (-1.4%)    ACAD (-1.57%)    ECOR (-13.74%)    DIS (-0.18%)    DFRG (1.48%)    CMG (-1.26%)    CGC (2.29%)    CCCL (-2.81%)

 PTI - Proteostasis Therapeutics

$1.07 [-0.07][-6.15%]

Next Earnings

8/8/2019

BMO

Recommend
Trade Idea »



OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $PTI

Service NameTrader% Success
Burdeshaw InvestingMatthew Burdeshaw55.00 %Subscribe

TRENDING ARTICLES



Proteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue Estimates

05/09/19
Proteostasis Therapeutics PTI came out with a quarterly loss of 0 28 per share versus the Zacks Consensus Estimate of a loss of 0 43 This compares to loss of 0 32 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings

Proteostasis (PTI) to Post Q1 Earnings: What's in Store?

05/07/19
Investor focus will remain on 160 Proteostasis Therapeutics Inc s PTI studies on triple combination regimes for cystic fibrosis when the company reports first quarter 2019 earnings results The company s performance over the previous four quarters has been mixed so far with two

Analysts Estimate Proteostasis Therapeutics (PTI) to Report a Decline in Earnings: What to Look Out for

05/01/19
Proteostasis Therapeutics PTI is expected to deliver a year over year decline in earnings on lower revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual results compare